NeuroStimX: Adaptive Brain-Computer Interface for Enhanced Cognitive Function

Publication ID: 24-11857733_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “NeuroStimX: Adaptive Brain-Computer Interface for Enhanced Cognitive Function,” Published Technical Disclosure No. 24-11857733_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857733_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,733.

Summary of the Inventive Concept

NeuroStimX is a revolutionary brain-computer interface system that integrates real-time neural activity feedback, adaptive neural stimulation, and personalized cognitive training protocols to enhance cognitive function and treat neurological disorders.

Background and Problem Solved

The original patent, 'Method and apparatus for stimulating neural activity', provided a foundational approach to neural stimulation using video and audio outputs. However, it was limited by its fixed stimulation parameters and lack of real-time brain activity feedback. NeuroStimX addresses these limitations by incorporating advanced brain-computer interface technology, enabling adaptive and personalized neural stimulation for more effective cognitive enhancement and treatment of neurological disorders.

Detailed Description of the Inventive Concept

NeuroStimX consists of a neural stimulation module, a brain-computer interface, and a personalized cognitive training protocol generator. The brain-computer interface monitors real-time neural activity, providing feedback to the neural stimulation module, which adaptively adjusts stimulation parameters to optimize cognitive function. The system can be integrated into various form factors, including wearable devices, and can be used for treating neurological disorders, enhancing cognitive performance, and providing neurofeedback training in virtual reality environments.

Novelty and Inventive Step

The new claims introduce a paradigm shift in neural stimulation technology by incorporating real-time brain activity feedback, adaptive stimulation parameters, and personalized cognitive training protocols. This inventive step enables a more effective and targeted approach to cognitive enhancement and treatment of neurological disorders, distinguishing NeuroStimX from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of NeuroStimX could include implantable devices, non-invasive transcranial stimulation, or even neurostimulation-based video games. Variations could also involve different brain-computer interface modalities, such as electroencephalography (EEG) or functional near-infrared spectroscopy (fNIRS).

Potential Commercial Applications and Market

NeuroStimX has vast commercial potential in the cognitive enhancement, neurological disorder treatment, and neurofeedback training markets. Target industries include healthcare, education, and gaming, with potential applications in military, sports, and corporate training environments.

CPC Classifications

SectionClassGroup
A A61 A61M21/02
A A61 A61B5/4064
A A61 A61N5/0618
A A61 A61N5/0622
A A61 A61M2021/0044
A A61 A61N2005/0663

Field of Art

Biomedical engineering, neurotechnology, brain-computer interfaces, neural stimulation systems with a focus on cognitive enhancement and neurological disorder treatment

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in neuroscience, biomedical engineering, or electrical engineering, possessing expertise in neural interface technologies, signal processing, and adaptive stimulation techniques

Obviousness Rationale

A PHOSITA would recognize that the disclosed neural stimulation system represents a predictable extension of existing neural interface technologies by integrating real-time feedback, adaptive stimulation, and personalized cognitive protocols. The core technical elements of neural stimulation, brain activity monitoring, and computational analysis are well-established in the prior art, making the PTD's variations obvious combinations of known techniques. The incremental improvements in adaptive stimulation and personalized protocols would be considered routine design optimization for a skilled practitioner in neural interface technologies.

Obvious Combinations & Variations

Source Patent Element
Video display and audio output for neural stimulation apparatus
PTD Variation
Virtual reality environment with adaptive neural stimulation feedback
Obviousness Reasoning
A PHOSITA would find it obvious to extend display technologies to create immersive neural stimulation environments using known interaction and feedback techniques
Source Patent Element
Processor-enabled neural stimulation device
PTD Variation
Deep learning diagnostic module for identifying neurological disorders and generating personalized stimulation protocols
Obviousness Reasoning
Applying machine learning techniques to neural stimulation is a predictable advancement using standard computational approaches in biomedical engineering
Source Patent Element
Basic neural stimulation apparatus
PTD Variation
Wearable device with flexible electrode array and wireless power harvesting
Obviousness Reasoning
Miniaturization and improved form factors are standard evolutionary steps in medical device design, representing obvious improvements to existing technologies
Source Patent Element
Neural activity stimulation method
PTD Variation
Real-time brain activity monitoring with adaptive stimulation parameter adjustment
Obviousness Reasoning
Closed-loop feedback systems are well-known in control engineering, making the adaptive stimulation approach a predictable technical solution
Source Patent Element
Information display for neural stimulation
PTD Variation
Personalized cognitive training protocols generated through neural activity analysis
Obviousness Reasoning
Customizing interventions based on individual physiological data is a standard approach in personalized medical technologies
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in the published technical disclosure would be considered obvious to a person having ordinary skill in the art at the time of invention, when viewed in light of US Patent 11857733. The incremental technical advancements represent predictable combinations of known neural stimulation techniques, adaptive computational methods, and personalized medical interface technologies, thereby rendering potential patent claims obvious and unpatentable.

Original Patent Information

Patent NumberUS 11,857,733
TitleMethod and apparatus for stimulating neural activity
Assignee(s)SYMBOLICS INC.